Cytovant
About:
Cytovant is a biopharmaceutical company focused on developing novel and innovative cellular therapeutics.
Website: http://www.cytovant.com/
Top Investors: Mirae Asset Venture Investment, Smilegate Investment, POSCO Venture Capital, BNH
Description:
Cytovant is a biopharmaceutical company focused on developing novel and innovative cellular therapeutics. The company focuses on developing modified T-cell receptor therapeutics and dendritic cell vaccines that target tumor antigens to improve tumor cells therapy and treatment.
Total Funding Amount:
$23.5M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Shanghai, Shanghai, China
Founded Date:
2019-04-01
Contact Email:
info(AT)cytovant.com
Founders:
Xinan Chen
Number of Employees:
1-10
Last Funding Date:
2020-04-03
IPO Status:
Private
Industries:
© 2025 bioDAO.ai